Outcomes of Patients with Down Syndrome and <i>CRLF2</i>-Overexpressing Acute Lymphoblastic Leukemia (ALL): A Report from the Children's Oncology Group (COG)Karen R. Rabin, Stephen P. Hunger, Sarah K. Tasian et al.|Blood|2020Cited by 2
Utility of a Second Interim Maintenance Phase to Improve Outcomes for Pediatric Acute Lymphoblastic Leukemia: A Report from the Children's Oncology GroupEtan Orgel, Mignon L. Loh, Michael J. Burke et al.|Blood|2024Cited by 0